Laura de las Heras
GlaxoSmithKline (Spain)(ES)
Publications by Year
Research Areas
Malaria Research and Control, Synthesis and Biological Evaluation, Computational Drug Discovery Methods, Synthesis and Reactivity of Heterocycles, Mosquito-borne diseases and control
Most-Cited Works
- → Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series(2010)107 cited
- → Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity(2016)58 cited
- → Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen(2017)56 cited
- → A Novel Synthesis of Enantiopure Octahydropyrrolo[3,4-b]pyrroles by Intramolecular [3 + 2] Dipolar Cycloaddition on Chiral Perhydro-1,3-benzoxazines(2002)32 cited
- → Identification of Selective Inhibitors of Plasmodium N-Myristoyltransferase by High-Throughput Screening(2019)25 cited
- → Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives(2014)13 cited
- → Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads(2021)10 cited
- → Entrevista Humberto Maturana(2012)3 cited
- → A decade of malaria phenotypic screenings: Key lessons on the discovery and development of new antimalarial drugs(2019)1 cited
- → Corrections to Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series(2010)1 cited